Ruggeri, Matteo
 Distribuzione geografica
Continente #
EU - Europa 2.763
NA - Nord America 2.375
AS - Asia 453
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 4
SA - Sud America 4
Totale 5.610
Nazione #
US - Stati Uniti d'America 2.350
IT - Italia 1.067
DE - Germania 596
SE - Svezia 331
CN - Cina 306
UA - Ucraina 268
IE - Irlanda 114
FR - Francia 110
GB - Regno Unito 83
FI - Finlandia 61
IN - India 48
TR - Turchia 39
ES - Italia 26
BE - Belgio 20
CA - Canada 20
CH - Svizzera 20
NL - Olanda 19
IR - Iran 15
PL - Polonia 10
SG - Singapore 10
JP - Giappone 8
KR - Corea 8
RU - Federazione Russa 8
HK - Hong Kong 7
AU - Australia 5
EU - Europa 5
HR - Croazia 5
RO - Romania 5
CZ - Repubblica Ceca 4
GR - Grecia 3
MX - Messico 3
EC - Ecuador 2
EE - Estonia 2
IL - Israele 2
KW - Kuwait 2
MD - Moldavia 2
MZ - Mozambico 2
PK - Pakistan 2
VN - Vietnam 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
ME - Montenegro 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 5.610
Città #
Chandler 434
Jacksonville 190
Ann Arbor 147
Ashburn 140
Milan 117
Plan 117
Dublin 113
San Mateo 112
Cattolica 110
Nanjing 90
Woodbridge 76
Wilmington 68
Bremen 67
Dearborn 59
Lawrence 57
Rome 57
Boston 53
Mountain View 46
Nanchang 42
Munich 40
Marseille 38
Seattle 37
Beijing 29
Redwood City 27
Frattamaggiore 26
Houston 25
Izmir 25
Turin 23
Shanghai 22
Boardman 19
Brussels 18
Redmond 17
Enterprise 16
Hebei 16
Jiaxing 16
Lancaster 16
New York 16
Kunming 15
Fairfield 14
Changsha 13
Hangzhou 13
Norwalk 13
Nürnberg 13
Augusta 12
Detroit 12
Torino 12
University Park 12
Bologna 11
Bari 10
Falls Church 10
Fremont 10
Princeton 10
Como 9
Guangzhou 9
Kish 9
Kraków 9
Napoli 9
Tianjin 8
Chicago 7
Moncalieri 7
Ottawa 7
Pune 7
Zurich 7
Arzano 6
Cambridge 6
Chennai 6
Florence 6
Getafe 6
Hong Kong 6
Mumbai 6
Shenyang 6
Taranto 6
Andover 5
Buccinasco 5
Gaziantep 5
Genoa 5
Los Angeles 5
Modena 5
Palermo 5
Parma 5
Pescia 5
Scicli 5
Trento 5
Amsterdam 4
Castellar 4
Crema 4
Düsseldorf 4
Gorgonzola 4
Icheon-si 4
London 4
Messina 4
Segrate 4
Selargius 4
Stimigliano 4
Toronto 4
Trapani 4
Washington 4
Zagreb 4
Zhengzhou 4
Albano Laziale 3
Totale 2.965
Nome #
I costi socio-sanitari dell’insufficienza renale cronica 550
L'analisi dei network organizzativinei sistemi sanitari: il caso della rete di emergenza della Regione Lazio 338
Economia sanitaria 167
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 153
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 119
Il modello WEF per la valutazione economica delle innovazioni terapeutiche in epatologia. 116
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use 110
Cost Effectiveness Analysis of Instanyl for the Treatment of Breakthrough Cancer Pain (BtcP) 109
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 107
The harmonic study: cost-effectiveness evaluation of the use of the ultrasonic scalpel in total thyroidectomy 104
Health Technology Assessment of the anti HCV strategies in Italy: evidences from the WEF Project 98
Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis 94
A cost effectiveness analysis of cataract surgery 94
Healthcare expenditure on prevention in the spending review era 94
Cohort Of Hcv Patients In Italy: Sizing And Treatments In A Sample Of Italian Hepatology Centers. 90
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study. 90
Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy 90
Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals 90
Extending influenza vaccination to individuals aged 50–64: A budget impact analysis 86
Economic evaluation of screening programs for HCV: evidence from literature. 86
Investigating the generalizability of Economic Evaluations conducted in Italy: a critical review 84
Harmonic study: A cost-effectiveness evaluation of ultrasonically activated shears for total thyroidectomy [Lo studio HARMONIC: Valutazione costo-efficacia dell'uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale] 83
Valutazione economica di Teysuno nel trattamento del Carcinoma gastrico avanzato 83
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 82
Valutazione economica dei programmi di screening contro il cancro del colon retto: evidenze indirette di lungo periodo e sostenibilita` finanziaria in un’ottica di programmazione regionale 80
Between rationing and rationalization. The challenges of the Italian National Health Service during the age of the great crisis 80
The cost-effectiveness of alternative strategies against HBV in Italy 78
L’utilizzo di modelli decisionali per le valutazioni economiche dei farmaci in Italia: stato dell’arte e prospettive future 78
Clinical and economic evaluation of tapentadol ER and oxycodone/naloxone. 75
Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy. 74
Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines. 73
Economic Evaluation of 5-Grass Pollen Tablets Versus Placebo in the Treatment of Allergic Rhinitis in Adults 73
A new decision model for economic evaluation of novel therapies for HCV 73
The minimum clinically important difference of the EQ-5D index. 71
Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster 71
THE HARMONIC STUDY: COST-EFFECTIVENESS EVALUATION OF THE USE OF THE ULTRASONIC SCALPEL IN TOTAL THYROIDECTOMY. 69
Come comunicare e trasferire i risultati delle valutazioni di HTA applicata alle vaccinazioni ai decision makers e agli stakeholders? il progetto dell’ISPOR Rome chapter 69
Cost effectiveness analysis of transnasal fentalyl citrate in the treatment of BTcP 68
Do Probability and Certainty Equivalent techniques lead to inconsistent results? Evidence from gambles involving life years and quality of life. 68
Lo studio HARMONIC: valutazione costo-efficacia dell’uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale 67
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 66
Normative needs in healthcare: toward a new conceptualization of equity and capabilities. 65
Economic Assessment of an Anti-HCV Screening Program in Italy 63
Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory. 63
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 61
New professional roles and patient satisfaction: evidence from a European survey along three clinical pathways 61
Valutazione economica di ranibizumab vs pegaptanib o vs terapia fotodinamica con verteporfina 60
Valutazione economica della tossina botulinica per la profilassi dell’emicrania cronica 60
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 59
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C 58
Cost effectiveness studies in HIV treatment with Lopinavir/Ritonavir: a Review. 58
Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World Cohort 56
New Healthcare Professional Roles in Europe: a Survey of Patients' Experiences and Views in Nine Countries 55
The cost effectiveness of Botox in Italian patients with chronic migraine. 53
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study. 52
Analisi economica per l’estensione della vaccinazione contro l’influenza agli individui di età 50-64: risparmi sociali e analisi di Budget Impact 51
Sevelamer Is Cost-Saving vs. Calcium Carbonate in Non-Dialysis-Dependent CKD Patients in Italy: A Patient-Level Cost-Effectiveness Analysis of the INDEPENDENT Study. 51
Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis. 51
Valutazione dei costi delle infezioni nosocomiali da E.Coli in un policlinico romano di 1700 posti letto 48
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 47
Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review 42
Cost-effectiveness analysis of Daclatasvir/Sofosbuvir for the treatment of the HCV patients failed after the first line with second generation of DAAs in Italy . 41
Is risk attitude really specific within the health context domain? Further evidence from an Italian survey using Probability Equivalent technique and face to face interviews 40
Cost effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C. 38
Setting research priorities in the feld of emergency management: which piece of information are you willing to pay more? 38
Introduction to essay health and economics 36
Is risk outcome specific within the health domain? 34
Totale 5.691
Categoria #
all - tutte 17.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201976 0 0 0 0 0 0 0 0 0 0 52 24
2019/2020728 194 40 33 26 52 36 106 13 68 42 45 73
2020/2021718 53 157 18 61 78 16 44 26 145 22 83 15
2021/2022677 58 68 20 27 31 26 54 108 30 43 84 128
2022/20231.319 147 186 96 223 91 170 56 113 163 17 46 11
2023/2024466 36 179 20 38 32 67 20 29 18 26 1 0
Totale 5.691